Rapid Micro Biosystems, Inc. (NASDAQ: RPID) is a prominent player in the life sciences technology sector. The company specializes in automation solutions that improve the manufacturing and release of healthcare products. As RPID prepares to release its fourth quarter and full year 2025 earnings on March 12, 2026, Wall Street anticipates an earnings per share (EPS) loss of $0.23 and revenue of approximately $10.9 million. Despite a negative price-to-earnings (P/E) ratio of -4.49, RPID remains a key participa ...